Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jerzy Jankun

Showing results (61-70 of 65) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 65 results.
The Journal of Urology|July 13, 2004
Optical characteristics of the canine prostate at 665 nm sensitized with tin etiopurpurin dichloride: need for real-time monitoring of photodynamic therapyJerzy Jankun, Lothar Lilge, Alexander Douplik, et al.
Molecular Cancer Therapeutics|May 30, 2006
Synthetic curcuminoids modulate the arachidonic acid metabolism of human platelet 12-lipoxygenase and reduce sprout formation of human endothelial cellsJerzy Jankun, Ansari M Aleem, Sylvia Malgorzewicz, et al.
International Journal of Molecular Medicine|October 4, 2007
Highly stable plasminogen activator inhibitor type one (VLHL PAI-1) protects fibrin clots from tissue plasminogen activator-mediated fibrinolysisJerzy Jankun, Ansari M Aleem, Steven H Selman, et al.
International Journal of Molecular Medicine|June 20, 2017
Formulation and characterization of EGCG for the treatment of superficial bladder cancerKatarzyna Dettlaff, Maciej Stawny, Magdalena Ogrodowczyk, et al.
International Journal of Molecular Medicine|February 9, 2006
Plasminogen activator inhibitor-1 is locked in active conformation and polymerizes upon binding ligands neutralizing its activityJerzy Jankun, Zofia Specht, Maria Szkudlarek, et al.
Pageof 7

Showing results (61-70 of 65) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 65 results.
The Journal of Urology|July 13, 2004
Optical characteristics of the canine prostate at 665 nm sensitized with tin etiopurpurin dichloride: need for real-time monitoring of photodynamic therapyJerzy Jankun, Lothar Lilge, Alexander Douplik, et al.
Molecular Cancer Therapeutics|May 30, 2006
Synthetic curcuminoids modulate the arachidonic acid metabolism of human platelet 12-lipoxygenase and reduce sprout formation of human endothelial cellsJerzy Jankun, Ansari M Aleem, Sylvia Malgorzewicz, et al.
International Journal of Molecular Medicine|October 4, 2007
Highly stable plasminogen activator inhibitor type one (VLHL PAI-1) protects fibrin clots from tissue plasminogen activator-mediated fibrinolysisJerzy Jankun, Ansari M Aleem, Steven H Selman, et al.
International Journal of Molecular Medicine|June 20, 2017
Formulation and characterization of EGCG for the treatment of superficial bladder cancerKatarzyna Dettlaff, Maciej Stawny, Magdalena Ogrodowczyk, et al.
International Journal of Molecular Medicine|February 9, 2006
Plasminogen activator inhibitor-1 is locked in active conformation and polymerizes upon binding ligands neutralizing its activityJerzy Jankun, Zofia Specht, Maria Szkudlarek, et al.
Pageof 7